It’s been a bountiful year for the stock market but that doesn’t mean there haven’t been laggards. The biotech industry, for example, has underperformed.…
Key takeaways The healthcare sector is coming off a year of underperformance as COVID sales declined, bond yields rose, and new weight-loss therapies caused.
In the just concluded trading week, the biotechnology sector outperformed the broader market, as evidenced by the Nasdaq Biotechnology Index (NBI) recording a notable increase of 6%.